DiamiR Biosciences Secures EU Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Differential Diagnosis of Amyotrophic Lateral Sclerosis
August 01, 2024 08:02 ET
|
DiamiR
NEW HAVEN, CT, and MONMOUTH JUNCTION, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced that...
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 30, 2023 07:01 ET
|
GreenLight Biosciences
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive...
GreenLight Biosciences Releases Inaugural Sustainability Report
April 12, 2023 06:59 ET
|
GreenLight Biosciences
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s...
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023 09:21 ET
|
Cytek Biosciences, Inc.
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly...
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
February 01, 2023 07:20 ET
|
GreenLight Biosciences
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
New funding announced to upgrade Canada’s biocontainment facilities
November 16, 2022 17:00 ET
|
Canada Foundation for Innovation
OTTAWA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The COVID-19 pandemic taught us that to tackle emerging global health issues countries must remain at the forefront of research. In Canada, this includes...
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022 16:30 ET
|
Cytek Biosciences, Inc.
Experienced Biotech, Pharmaceutical Industry Leader to Guide Operations Growth and Scalability FREMONT, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today...
CALADRIUS BIOSCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CLBS and Encourages Investors to Contact the Firm
May 02, 2022 13:08 ET
|
Bragar Eagel & Squire
NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
May 11, 2021 16:47 ET
|
Interpace Biosciences, Inc.
● Q1 Revenue of $9.8 Million is Company’s Highest as Combined Molecular Diagnostics and Pharma Services Business ● Q2 Revenue Expected to Exceed $11 million ● On Track to Exceed Full Year 2021...
Cytek® Biosciences Appoints Allen Poirson as Senior Vice President of Marketing and Corporate Development
April 28, 2021 10:00 ET
|
Cytek Biosciences
FREMONT, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc., a leading life sciences technology company, today announced that Allen Poirson, Ph.D. has been appointed as the senior...